Pangenotypic direct-acting antiviral combinations
WHO Essential Medicine EML section: Pangenotypic direct-acting antiviral combinations
Label status: label not available in our sources
This is information only, not a prescription. Talk to a doctor or pharmacist before taking any medicine. For an overdose or poisoning, call 102.
Daclatasvir is an essential medicine on the WHO Model List, listed under: Pangenotypic direct-acting antiviral combinations. A product label is not available in our sources.. Pangenotypic direct-acting antiviral combinations. What it is used for: Listed for: Pangenotypic direct-acting antiviral combinations (WHO EML section heading). generated by SI from cited sources · general information, not a diagnosis · consult a health professional
Sources: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
Listed for: Pangenotypic direct-acting antiviral combinations (WHO EML section heading).
For a suspected overdose or poisoning, call 102 now and go to the nearest emergency hospital.
Call 102What is Daclatasvir used for?
It is listed for: Pangenotypic direct-acting antiviral combinations (WHO Model List section).
Is Daclatasvir an essential medicine?
Yes, it is on the WHO Model List of Essential Medicines.
What is the dose of Daclatasvir?
Not provided here. Ask a doctor or pharmacist.
What is Daclatasvir?
Daclatasvir is an essential medicine on the WHO Model List, listed under: Pangenotypic direct-acting antiviral combinations. A product label is not available in our sources.
Sources: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
WHO Model List of Essential Medicines, 23rd list (2023), World Health Organization